Heparin Sodium in Sodium Chloride
These highlights do not include all the information needed to use HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION safely and effectively. See full prescribing information for HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION. HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION , for intravenous use Initial U.S. Approval:
Approved
Approval ID
a3041c04-0ea8-4d36-81ce-c5091c906316
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 15, 2023
Manufacturers
FDA
B. Braun Medical Inc.
DUNS: 002397347
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Heparin Sodium in Sodium Chloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0264-9872
Application NumberNDA019953
Product Classification
M
Marketing Category
C73594
G
Generic Name
Heparin Sodium in Sodium Chloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 15, 2023
FDA Product Classification
INGREDIENTS (5)
SODIUM PHOSPHATE, DIBASICInactive
Quantity: 0.43 g in 100 mL
Code: GR686LBA74
Classification: IACT
HEPARIN SODIUMActive
Quantity: 200 [USP'U] in 100 mL
Code: ZZ45AB24CA
Classification: ACTIM
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 0.9 g in 100 mL
Code: 451W47IQ8X
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Quantity: 0.037 g in 100 mL
Code: XF417D3PSL
Classification: IACT